ֱ

Spotlight On

ASCO: Multiple Myeloma

American Society of Clinical Oncology

More in ASCO: Multiple Myeloma

Current Approaches to Smoldering Multiple Myeloma

For high-risk patients, classic "watch and wait" may cede to early therapy

Jul 12, 2024
A computer rendering of multiple myeloma cells in the blood.
Beyond BCMA-Directed CAR T-Cell Therapy

Emerging targets and treatment pathways in multiple myeloma

Jun 21, 2024
A computer rendering of multiple myeloma cells in the blood.
Quadruplet Regimens Have Become Standard for Multiple Myeloma

Could quintuplet therapy be next?

May 31, 2024
A close up photo of an intravenous drip bag and and out of focus nurse.
Advances in CAR T-Cell Therapy for Multiple Myeloma

As approved products move to earlier use, novel approaches aim to improve responses after relapse

May 31, 2024
A computer rendering of a CAR-T cell attacking a multiple myeloma cell.

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes

0.50 CME Credits
Enhancing Vaccine Uptake in Older Adults: Supporting Conversations With Your Patients

0.50 CME Credits
The Latest Evidence for Integrating Biomarkers and Prognostic Factors Into Treatment Plans for Patients With Rheumatoid Arthritis

0.25 CME Credits
Leveraging the Latest Data to Guide Precision Medicine in Rheumatoid Arthritis